Shares of Annovis Bio Inc. (ANVS) have experienced a 70% decline from their 52-week high of $22.49, reached in December last year, and trade around $6.
This clinical-stage, drug platform company is focused on addressing neurodegeneration, such as Alzheimer's Disease, Parkinson's Disease, and other chronic neurodegenerative diseases.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.